The European Patent Office had revised a patent granted to Edinburgh University and the biotech firm Stem Cell Services to remove the possibility that it could cover a method of cloning humans.
According to Reuters, the patent office has admitted that a reference in the patent to human cells had been missed by officials during the checking procedure.